Investors: This Is the Gold Standard of Biotech Trials
Biotech companies can use several different options when designing a clinical trial. But not all study designs are created equal. In this video clip from "The Pharma & Biotech Show," recorded on Feb. 9, Dr. Frank David, author of The Pharmagellan Guide to Analyzing Biotech Clinical Trials, describes one of the best study designs out there and some challenges biotechs face when creating clinical trials.
Source Fool.com
